FDA Gives First-Ever Approval For A Drug That Delays Type 1 Diabetes
November 18, 2022
Morning Briefing
The monoclonal antibody — manufactured by ProventionBio and Sanofi and will be marketed under the name Tzield — has been authorized by the FDA for use only in patients who have stage 2 type 1 diabetes, with an aim at delaying the onset of stage 3 of the disease.
Hay más infecciones sexuales y empresas producen más tests caseros… ¿son confiables?
By Liz Szabo
November 18, 2022
KFF Health News Original
Datos preliminares para 2021 mostraron cerca de 2.5 millones de casos reportados de clamidia, gonorrea y sífilis en el país, según los Centros para el Control y Prevención de Enfermedades.
First Edition: Nov. 18, 2022
November 18, 2022
Morning Briefing
Today’s early morning highlights from the major news organizations.
Path Cleared for Georgia to Launch Work Requirements for Medicaid
By Andy Miller and Sam Whitehead
November 18, 2022
KFF Health News Original
Federal officials have apparently stopped fighting Georgia’s plan for a limited Medicaid expansion that includes work requirements. The plan, a key policy of Republican Gov. Brian Kemp’s, would cover a much smaller portion of the population: those who can work or volunteer 80 hours a month.
Mistrust and Polarization Steer Rural Governments to Reject Federal Public Health Funding
By Jazmin Orozco Rodriguez
November 18, 2022
KFF Health News Original
As the covid-19 pandemic grinds on, Elko County, Nevada, still lacks a public health department. Yet its elected leaders rejected federal funds that could have helped it create one. Decisions like the one in Elko, and ones made by officials with other state and local governments, leave health experts concerned about whether the country’s public health infrastructure will be prepared to handle future health challenges.
As STDs Proliferate, Companies Rush to Market At-Home Test Kits. But Are They Reliable?
By Liz Szabo
Photos by Eric Harkleroad
November 18, 2022
KFF Health News Original
The popularity of at-home covid tests has amplified calls from public health researchers and diagnostic companies to make home testing similarly routine for sexually transmitted diseases. But FDA guidelines are lagging.
KHN’s ‘What the Health?’: The Changing of the Guard
November 17, 2022
KFF Health News Original
Democrats retained control of the U.S. Senate in the midterm elections, while Republicans won a majority in the House, giving them the ability to block items on President Joe Biden’s agenda. Meanwhile, the lame-duck, Democratic-led Congress won’t have the votes to pass abortion rights legislation, although they may try to undo some long-standing anti-abortion policies in federal spending bills. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Victoria Knight of Axios, and Alice Miranda Ollstein of Politico, join KHN’s Julie Rovner to discuss these topics and more.
Viewpoints: Public Must Know The Dangers Of Crisis Pregnancy Centers; Why Is RSV So Severe This Year?
November 17, 2022
Morning Briefing
Editorial writers tackle crisis pregnancy centers, RSV, polio and more.
Texas Lawmakers Want To Criminalize Gender Care For Minors
November 17, 2022
Morning Briefing
Some lawmakers are stepping up efforts to restrict gender-affirming care for minors, The Hill reports, with at least three new bills aiming to classify treatment as child abuse. Health news from New Hampshire, Montana, New Jersey, Connecticut, and Ohio are also reported.
OptumRx Will Cover Humira Biosimilars Alongside Original Drug
November 17, 2022
Morning Briefing
The move will, Modern Healthcare says, permit members to continue using the brand name medicine or swap to a lower cost alternative. Bloomberg highlights that UnitedHealth’s choice to keep both versions available is a partial win for the original drugmaker.
Primary Care Doctors Are Burning Out — Young Ones Particularly
November 17, 2022
Morning Briefing
Stat’s headline says across 10 wealthy countries, the stress of the pandemic is contributing to high burnout rates, making doctors feel like their delivery of care is failing. Axios says that half of primary care physicians under age 55 in the U.S. say they’re burned out and many may leave the profession.
FDA Moves To Encourage OTC Overdose Drug Distribution
November 17, 2022
Morning Briefing
News outlets report on an FDA notice asking naloxone makers to start discussions about a switch from prescription-only models for the opioid overdose-reversal drug to over the counter. The matter is complex, though, and centers only on some versions of the medication.
Spotlight Falls On Surprising Covid Symptom: Black Tongue
November 17, 2022
Morning Briefing
Tongue discoloration is reportedly getting fresh attention as a lesser-known covid symptom of covid. Meanwhile, CDC data shows new covid subvariants have overtaken BA.5 for the first time in the U.S. And drugmakers who make treatments are struggling to keep up.
More Home Births Happened In 2021 Than For 30 Years
November 17, 2022
Morning Briefing
Media outlets cover a report from the CDC showing 2021 home birth figures jumped 12% from 2020’s total. But they still remain uncommon at 1.26% of all U.S. births. Separately, metro Atlanta abortion providers saw a surge in calls after Georgia’s abortion law was blocked.
FDA Clears Way For Lab-Grown Meat
November 17, 2022
Morning Briefing
Upside Foods’ cultivated chicken product was certified as safe for human consumption by the Food and Drug Administration. The move is anticipated to pave the way for a flood of available lab-grown meat products in the U.S.
Research Roundup: Leprosy; Covid; Malaria
November 17, 2022
Morning Briefing
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Morning Briefing for Thursday, November 17, 2022
November 17, 2022
Morning Briefing
Thursday’s roundup covers the RSV/flu surges, medical marijuana, opioids, covid symptoms, variants, doctor burnout, drug prices, and more.
Monkeypox A Contributing Factor In Indiana Death, Officials Say
November 17, 2022
Morning Briefing
The state health commissioner warned that “this disease is still circulating and can cause severe illness and death.” Also in the news: dengue, Ebola, Hendra, and bird flu.
First Bill Solely Related to Marijuana Policy Heads To Biden’s Desk
November 17, 2022
Morning Briefing
The legislation facilitates medical marijuana research and gives doctors greater flexibility to talk about the drug with patients. Other congressional news reports on drug pricing, online safety, and CDC oversight.
Pediatricians Fighting RSV Wave Say It’s Time For National Emergency
November 17, 2022
Morning Briefing
With a surge of pediatric respiratory illnesses overwhelming emergency departments and pediatric offices, doctor groups are asking the Biden administration for aid that a declaration of a national emergency and public health emergency could provide. Other news on RSV and seasonal flu is also reported.